This study aims to determine and analyze the effect of Liquidity (Current Ratio), Firm Size, and Profitability (Return On Assets) on Stock Price, both partially and simultaneously, in pharmaceutical sub-sector companies listed on the Indonesia Stock Exchange during the 2020–2025 period. This research uses a quantitative approach with secondary data obtained from annual financial reports published on the official website of the Indonesia Stock Exchange (www.idx.co.id). The sample was selected using a purposive sampling technique, resulting in 7 pharmaceutical sub-sector companies observed over a 6-year period, producing a total of 42 data observations. The data analysis technique used is multiple linear regression analysis, processed with SPSS version 26. The results show that, partially, Liquidity, Firm Size, and Profitability have no significant effect on Stock Price. Simultaneously, the three variables also have no significant effect on Stock Price, with an Adjusted R Square value of 0.043 or 4.3%, indicating that the variation in Stock Price is largely explained by other factors outside this research model, such as macroeconomic conditions, market sentiment, and government policy.
Copyrights © 2026